1. How Can Erythropoeitin‐Stimulating Agent Use be Reduced in Chronic Dialysis Patients?: The Use of Iron Supplementation to Reduce ESA Dosing in Hemodialysis. Issue 5 (14th June 2013) Authors: Shirazian, Shayan; Grant, Candace; Miller, Ilene; Fishbane, Steven Editors: Fishbane, Steven N. Journal: Seminars in dialysis Issue: Volume 26:Issue 5(2013) Page Start: 534 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. How Can Erythropoeitin‐Stimulating Agent Use be Reduced in Chronic Dialysis Patients?: Can Reduction of Inflammation Improve ESA Dose Response?. Issue 5 (5th June 2013) Authors: Kovesdy, Csaba P Editors: Fishbane, Steven N. Journal: Seminars in dialysis Issue: Volume 26:Issue 5(2013) Page Start: 540 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. How Can Erythropoeitin‐Stimulating Agent Use be Reduced in Chronic Dialysis Patients?. Issue 5 (14th June 2013) Authors: Shah, Hitesh H.; Fishbane, Steven N.; Fishbane, Steven N. Journal: Seminars in dialysis Issue: Volume 26:Issue 5(2013) Page Start: 543 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. How Can Erythropoeitin‐Stimulating Agent Use be Reduced in Chronic Dialysis Patients?. Issue 5 (5th June 2013) Authors: Battistella, Marisa; Chan, Christopher T; Fishbane, Steven N. Journal: Seminars in dialysis Issue: Volume 26:Issue 5(2013) Page Start: 537 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. How Can Erythropoeitin‐Stimulating Agent Use be Reduced in Chronic Dialysis Patients?. Issue 5 (14th June 2013) Authors: Singh, Ajay K.; Fishbane, Steven N. Journal: Seminars in dialysis Issue: Volume 26:Issue 5(2013) Page Start: 531 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗